07:00 , Jul 28, 2003 |  BioCentury  |  Emerging Company Profile

Corporate Profile

igeneon AG Vienna, Austria Technology: Cancer immunotherapies Disease focus: Epithelial cancer Clinical status: Phase II/III Founded: 1999 by Hans Loibner and Helmut Eckert Corporate partners: Protein Design Labs, Novartis, BioInvent, Diomeda, Glycart, Immunicon University collaborators:...